UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

European journal of nuclear medicine and molecular imaging, 2009-07, Vol.36 (7), p.1138-1146

2009

Volltextzugriff (PDF)

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

European journal of nuclear medicine and molecular imaging, 2003-10, Vol.30 (10), p.1338-1347

2003

Volltextzugriff (PDF)

Localisation and mechanism of renal retention of radiolabelled somatostatin analogues

European journal of nuclear medicine and molecular imaging, 2005-10, Vol.32 (10), p.1136-1143

2005

Volltextzugriff (PDF)

Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences

Nuclear medicine and biology, 2007-08, Vol.34 (6), p.633-641

2007

Volltextzugriff (PDF)

[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy

International journal of cancer, 2001-06, Vol.92 (5), p.628-633

2001

Volltextzugriff (PDF)

Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats

European journal of nuclear medicine and molecular imaging, 2007-02, Vol.34 (2), p.219-227

2007

Volltextzugriff (PDF)

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy

The Journal of nuclear medicine (1978), 2002-12, Vol.43 (12), p.1650-1656

2002

Volltextzugriff (PDF)

Anticancer Activity of Targeted Proapoptotic Peptides

The Journal of nuclear medicine (1978), 2006-01, Vol.47 (1), p.122-129

2006

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy In Vitro Using [111In-DTPA0]Octreotide

The Journal of nuclear medicine (1978), 2003-01, Vol.44 (1), p.98-104

2003

Volltextzugriff (PDF)

Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog

The Journal of nuclear medicine (1978), 2004-10, Vol.45 (10), p.1716

2004

Volltextzugriff (PDF)

[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate

European journal of nuclear medicine and molecular imaging, 2006-07, Vol.33 (7), p.831-840

2006

Volltextzugriff (PDF)

D-Lysine Reduction of Indium-111 Octreotide and Yttrium-90 Octreotide Renal Uptake

The Journal of nuclear medicine (1978), 1997-12, Vol.38 (12), p.1929-1933

1997

Volltextzugriff (PDF)

The addition of DTPA to [177Lu-DOTA0, Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity

European journal of nuclear medicine and molecular imaging, 2003-02, Vol.30 (2), p.312-315

2003

Volltextzugriff (PDF)

[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate

European journal of nuclear medicine and molecular imaging, 2006-07, Vol.33 (7), p.831-840

2006

Volltextzugriff (PDF)

Uptake of [111In-DTPA0]Octreotide in the Rat Kidney Is Inhibited by Colchicine and Not by Fructose

The Journal of nuclear medicine (1978), 2004-04, Vol.45 (4), p.709-713

2004

Volltextzugriff (PDF)

Pre‐clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy

International journal of cancer, 1998-01, Vol.75 (3), p.406-411

1998

Volltextzugriff (PDF)

Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs

Cancer biotherapy & radiopharmaceuticals, 2007-02, Vol.22 (1), p.151-159

2007

Volltextzugriff (PDF)

Anti‐tumor effect and increased survival after treatment with [177Lu‐DOTA0,Tyr3]octreotate in a rat liver micrometastases model

International journal of cancer, 2003-04, Vol.104 (3), p.376-379

2003

Volltextzugriff (PDF)

Inhibition of Renal Uptake of Indium-111-DTPA-Octreotide In Vivo

The Journal of nuclear medicine (1978), 1996-08, Vol.37 (8), p.1388-1392

1996

Volltextzugriff (PDF)

Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount

European journal of nuclear medicine, 1999-07, Vol.26 (7), p.693-698

1999

Volltextzugriff (PDF)

Norharman and alcohol-dependency in male Wistar rats

European neuropsychopharmacology, 2004-10, Vol.14 (5), p.361-366

2004

Volltextzugriff (PDF)

Radiolabelling DOTA-peptides with 68Ga

European journal of nuclear medicine and molecular imaging, 2005-04, Vol.32 (4), p.478-485

2005

Volltextzugriff (PDF)

Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3

Nuclear medicine and biology, 2004-08, Vol.31 (6), p.821-824

2004

Volltextzugriff (PDF)

[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy

International journal of cancer, 2001-06, Vol.92 (5), p.628-633

2001

Volltextzugriff (PDF)

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (3), p.437-441

1998

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(72)
Male
(53)
Animals
(49)
Rats
(43)
Humans
(40)
Biological And Medical Sciences
(36)
Medical Sciences
(31)
Female
(25)
Octreotide - Analogs & Derivatives
(23)
Tissue Distribution
(23)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Middle Aged
(19)
Rats, Inbred Lew
(19)
Adult
(16)
Radiopharmaceuticals - Pharmacokinetics
(16)
Aged
(15)
Oncology
(15)
Tumors
(14)
Rats, Wistar
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Localisation and mechanism of renal retention of radiolabelled somatostatin analogues

Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences

[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy

Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy

Anticancer Activity of Targeted Proapoptotic Peptides

Peptide Receptor Radionuclide Therapy In Vitro Using [111In-DTPA0]Octreotide

Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog

[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate

D-Lysine Reduction of Indium-111 Octreotide and Yttrium-90 Octreotide Renal Uptake

The addition of DTPA to [177Lu-DOTA0, Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity

[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate

Uptake of [111In-DTPA0]Octreotide in the Rat Kidney Is Inhibited by Colchicine and Not by Fructose

Pre‐clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy

Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs

Anti‐tumor effect and increased survival after treatment with [177Lu‐DOTA0,Tyr3]octreotate in a rat liver micrometastases model

Inhibition of Renal Uptake of Indium-111-DTPA-Octreotide In Vivo

Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount

Norharman and alcohol-dependency in male Wistar rats

Radiolabelling DOTA-peptides with 68Ga

Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3

[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

Suchergebnisse filtern